(Q41926736)
Statements
Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria (English)
Jiao X
Liu GY
Shan CO
Zhao X
Li XW
Gathmann I
1 September 1997